Decreased urine concentration after Trilostane (Vetoryl) in dogs

656 reports to the FDA describe decreased urine concentration in dogs given Trilostane. That is 5.5% of all reports for this medicine, compared with 0.4% across reports for all dog medicines, so it is reported unusually often with this medicine.

656Reports
53%Marked serious
1.8%Recovered
12%Died or euthanised
79 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
11 2.4%
1–2 days
11 2.4%
3–7 days
22 4.8%
1–4 weeks
86 19%
Over a month
331 72%

How the animals did

Recovered
8 1.2%
Recovered with lasting effects
4 0.6%
Still unwell when reported
101 15%
Died
20 3.0%
Euthanised
57 8.7%
Not known
466 71%

Problems reported at the same time

Age of the animals

Under 1 year
0
1–3 years
0
4–7 years
54
8–11 years
326
12+ years
264

About this medicine

Trilostane treats Cushing's disease (an overactive adrenal gland).

Products with this ingredient include Vetoryl. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Trilostane cause decreased urine concentration in dogs?
656 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 79 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Decreased urine concentration with similar medicines

All reported side effects of Trilostane in dogs · Medicines most reported with decreased urine concentration